REPORTS

Let’s Pullulate and Expand Your Business

Microbiome Technologies Market - Global Professional Analysis and Forecast to 2026

Oct 14, 2019  |  201 PAGES  |  REPORT CODE: CMM209297
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Microbiome Technologies market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.4% during the forecast period.

This report presents the market size and development trends by detailing the Microbiome Technologies market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Microbiome Technologies market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Microbiome Technologies industry and will help you to build a panoramic view of the industrial development.

Microbiome Technologies Market, By Type:

  • Prebiotics

  • Probiotics

  • Fecal Microbiota Transplantation

  • Small Molecules

Microbiome Technologies Market, By Application:

  • Therapeutics

  • Diagnostics

Some of the leading players are as follows:

  • Vedanta BioSciences

  • Enterome Bioscience

  • Series Therapeutics

  • Synthetic Biologics

  • Second Genome

  • Yakult

  • Metabiomics Corporation

  • Second Genome Inc.

  • DuPont

  • MicroBiome Therapeutics LLC

  • ViThera Pharmaceuticals

  • Osel

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Microbiome Technologies Market: Technology Type Analysis

  • 4.1 Microbiome Technologies Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Microbiome Technologies Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Prebiotics

    • 4.3.2 Probiotics

    • 4.3.3 Fecal Microbiota Transplantation

    • 4.3.4 Small Molecules

5 Microbiome Technologies Market: Product Analysis

  • 5.1 Microbiome Technologies Product Market Share Analysis, 2018 & 2026

  • 5.2 Microbiome Technologies Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Microbiome Technologies Market: Application Analysis

  • 6.1 Microbiome Technologies Application Market Share Analysis, 2018 & 2026

  • 6.2 Microbiome Technologies Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Therapeutics

    • 6.3.2 Diagnostics

7 Microbiome Technologies Market: Regional Analysis

  • 7.1 Microbiome Technologies Regional Market Share Analysis, 2018 & 2026

  • 7.2 Microbiome Technologies Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Vedanta BioSciences

    • 9.1.1 Vedanta BioSciences Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Enterome Bioscience

    • 9.2.1 Enterome Bioscience Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Series Therapeutics

    • 9.3.1 Series Therapeutics Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Synthetic Biologics

    • 9.4.1 Synthetic Biologics Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Second Genome

    • 9.5.1 Second Genome Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Yakult

    • 9.6.1 Yakult Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Metabiomics Corporation

    • 9.7.1 Metabiomics Corporation Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Second Genome Inc.

    • 9.8.1 Second Genome Inc. Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 DuPont

    • 9.9.1 DuPont Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 MicroBiome Therapeutics LLC

    • 9.10.1 MicroBiome Therapeutics LLC Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 ViThera Pharmaceuticals

    • 9.11.1 ViThera Pharmaceuticals Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Osel

    • 9.12.1 Osel Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

 

The List of Tables and Figures (Totals 74 Figures and 132 Tables)

  • Figure Prebiotics Microbiome Technologies market, 2015 - 2026 (USD Million)

  • Figure Probiotics Microbiome Technologies market, 2015 - 2026 (USD Million)

  • Figure Fecal Microbiota Transplantation Microbiome Technologies market, 2015 - 2026 (USD Million)

  • Figure Small Molecules Microbiome Technologies market, 2015 - 2026 (USD Million)

  • Figure Therapeutics market, 2015 - 2026 (USD Million)

  • Figure Diagnostics market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Microbiome Technologies market, by country, 2015 - 2026 (USD Million)

  • Table North America Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table North America Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table North America Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Canada Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Canada Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Europe Microbiome Technologies market, by country, 2015 - 2026 (USD Million)

  • Table Europe Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Europe Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Europe Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Germany Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Germany Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table France Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table France Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Italy Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Italy Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Spain Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Spain Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Microbiome Technologies market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table China Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table China Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Japan Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Japan Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table India Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table India Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Microbiome Technologies market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table MEA Microbiome Technologies market, by country, 2015 - 2026 (USD Million)

  • Table MEA Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table MEA Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table MEA Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Microbiome Technologies market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Microbiome Technologies market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Microbiome Technologies market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Vedanta BioSciences Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Enterome Bioscience Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Series Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Synthetic Biologics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Second Genome Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Yakult Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Metabiomics Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Second Genome Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DuPont Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MicroBiome Therapeutics LLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ViThera Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Osel Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top